Vatelizumab, CAS 1238217-55-4

Product Description: Vatelizumab (GBR500) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2). Vatelizumab can be used for the research of multiple sclerosis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Johanna Breuer, et al. VLA-2 blockade in vivo by vatelizumab induces CD4+FoxP3+ regulatory T cells. Int Immunol. 2019 May 21;31(6):407-412.

CAS Number: 1238217-55-4

Molecular Weight: N/A

Compound Purity: 99.90

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99524-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99524-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated